European Case Law Identifier: | ECLI:EP:BA:2018:T105012.20180122 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 22 January 2018 | ||||||||
Case number: | T 1050/12 | ||||||||
Application number: | 05000057.9 | ||||||||
IPC class: | A61K 35/34 C12N 5/08 A61P 13/02 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence | ||||||||
Applicant name: | UNIVERSITY OF PITTSBURGH | ||||||||
Opponent name: | Innovacell Biotechnologie AG | ||||||||
Board: | 3.3.01 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Referral to the Enlarged Board of Appeal - (no) Remittal to the department of first instance - (no) Novelty - (no) - meeting abstracts available to library users before priority date - enabling disclosure for medical indication Amendments - intermediate generalisation Late-filed auxiliary requests |
||||||||
Catchwords: |
Meeting abstracts published in a supplement to a regular volume of a scientific journal found to be publicly available before the priority date of the patent on the basis of library date-stamps and accompanying declarations of the librarians (see Reasons 3.1 to 3.5). |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121050eu1.html
Date retrieved: 17 May 2021